$VERA
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clinical trial. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
Healthcare
Sector
Biotechnology
Industry
Marshall W. Fordyce
CEO
152
Employees
$39.32
Current Price
$3.05B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 7 | 7 | $1,406,040.81 | 33,490 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 7 | 7 | $1,406,040.81 | 33,490 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 7 | 7 | $1,406,040.81 | 33,490 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Feb 23, 2026 | Brenner Robert Chief Medical Officer | Sale | 2,151 | $41.98 | $90,307.37 | View Details |
| Feb 23, 2026 | Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR | Sale | 3,117 | $41.98 | $130,863.82 | View Details |
| Feb 23, 2026 | Grant Sean CHIEF FINANCIAL OFFICER | Sale | 4,949 | $41.98 | $207,778.32 | View Details |
| Feb 23, 2026 | Fordyce Marshall Director | Sale | 16,925 | $41.98 | $710,577.51 | View Details |
| Feb 23, 2026 | JOHNSON DAVID LEE Chief Operating Officer | Sale | 2,579 | $41.98 | $108,276.48 | View Details |
| Feb 23, 2026 | Turner William D. Chief Regulatory Officer | Sale | 2,187 | $41.98 | $91,818.79 | View Details |
| Feb 23, 2026 | Skelton Laurence Matthew Chief Commercial Officer | Sale | 1,582 | $41.98 | $66,418.53 | View Details |
10 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
EPS
Estimated-$1.34
ActualN/A
Revenue
EstimatedN/A
ActualN/A
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies: